Cargando…

Pulsed immune reconstitution therapy in multiple sclerosis

Whereas drugs used for maintenance/escalation therapy do not maintain their beneficial effect after cessation of therapy, some new highly effective therapies can show prolonged treatment effects after a short treatment course. Such therapies have been named pulsed immune reconstitution therapies or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorensen, Per Soelberg, Sellebjerg, Finn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440030/ https://www.ncbi.nlm.nih.gov/pubmed/30944586 http://dx.doi.org/10.1177/1756286419836913

Ejemplares similares

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
por: Romme Christensen, Jeppe, et al.
Publicado: (2012)

Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2012)

Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis
por: Sellebjerg, Finn, et al.
Publicado: (2012)

Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
por: AlSharoqi, Isa Ahmed, et al.
Publicado: (2020)

Progressive multiple sclerosis, cognitive function, and quality of life
por: Højsgaard Chow, Helene, et al.
Publicado: (2018)

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
por: Dogonowski, Anne-Marie, et al.
Publicado: (2016)

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Christensen, Jeppe Romme, et al.
Publicado: (2013)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

The Danish Multiple Sclerosis Treatment Register
por: Magyari, Melinda, et al.
Publicado: (2016)

The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis
por: Rolla, Simona, et al.
Publicado: (2020)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis
por: Hammerstad, Sara Salehi, et al.
Publicado: (2021)

Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis
por: Carrión, Belinda, et al.
Publicado: (2021)

The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus
por: De Sèze, Jerome, et al.
Publicado: (2022)

Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis
por: Boyko, Alexey N, et al.
Publicado: (2018)

A systematic review of the incidence and prevalence of cancer in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

The gut microbiota in multiple sclerosis varies with disease activity
por: Thirion, Florence, et al.
Publicado: (2023)

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control
por: von Essen, Marina Rode, et al.
Publicado: (2023)

Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial
por: Højsgaard Chow, Helene, et al.
Publicado: (2021)

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report
por: Garbo, Riccardo, et al.
Publicado: (2021)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
por: Filikci, Zuhal, et al.
Publicado: (2022)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Multiple sclerosis impairs regional functional connectivity in the cerebellum()
por: Dogonowski, Anne-Marie, et al.
Publicado: (2013)

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy
por: Hecker, Michael, et al.
Publicado: (2023)

The relation between inflammation and neurodegeneration in multiple sclerosis brains
por: Frischer, Josa M., et al.
Publicado: (2009)

Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis
por: Andersen, Johanna Balslev, et al.
Publicado: (2022)

Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2015)

The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies
por: Amoriello, Roberta, et al.
Publicado: (2020)

Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis
por: Søndergaard, Helle Bach, et al.
Publicado: (2021)

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
por: Metz, Imke, et al.
Publicado: (2011)

Imaging cortical multiple sclerosis lesions with ultra-high field MRI
por: Madsen, Mads A.J., et al.
Publicado: (2021)

Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
por: von Essen, Marina Rode, et al.
Publicado: (2022)

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
por: Comi, Giancarlo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_akfqhi4ejooa1899qv7ihtvobj